Serina Therapeutics, Inc. (SER)
2.105
-0.14
(-6.44%)
USD |
NYAM |
Sep 21, 16:00
2.105
0.00 (0.00%)
After-Hours: 20:00
Serina Therapeutics Shareholders Equity (Quarterly) : 18.73M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.73M |
| March 31, 2026 | 17.63M |
| December 31, 2025 | -0.037M |
| September 30, 2025 | 1.76M |
| June 30, 2025 | 1.802M |
| March 31, 2025 | 1.701M |
| September 30, 2024 | -13.77M |
| June 30, 2024 | -16.36M |
| March 31, 2024 | -4.309M |
| December 31, 2023 | 4.11M |
| September 30, 2023 | 8.422M |
| June 30, 2023 | -22.18M |
| March 31, 2023 | -19.89M |
| December 31, 2022 | -17.21M |
| September 30, 2022 | -15.10M |
| June 30, 2022 | -13.22M |
| March 31, 2022 | -11.55M |
| Date | Value |
|---|---|
| December 31, 2021 | -11.83M |
| September 30, 2021 | -9.936M |
| June 30, 2021 | -8.252M |
| March 31, 2021 | -6.062M |
| December 31, 2020 | -5.116M |
| September 30, 2020 | -3.651M |
| June 30, 2020 | -2.444M |
| March 31, 2020 | -0.739M |
| December 31, 2019 | 2.218M |
| September 30, 2019 | 4.339M |
| June 30, 2019 | 6.747M |
| March 31, 2019 | 9.321M |
| December 31, 2018 | 7.447M |
| September 30, 2018 | 9.865M |
| June 30, 2018 | 11.27M |
| March 31, 2018 | 8.014M |
| December 31, 2017 | 7.28M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.81M |
| Total Liabilities (Quarterly) | 7.084M |
| Debt to Equity Ratio | 0.1713 |
| Current Ratio | 6.653 |
| Net Debt Paydown Yield | -1.14% |